• Shortage Of Cancer Drugs Plagues United States
    A shortage of low-cost generic cancer drugs is dragging on in the United States. "Oncologists are concerned that the alternatives to two crucial chemotherapy drugs are far less effective in treating certain cancers, and are sometimes more toxic," per The New York Times. "The backup therapies or lack thereof, they say, pose particularly troubling prospects for patients with ovarian, testicular, breast, lung and head and neck cancers."
  • Under Armour Shakes Up C-Suite
    Under Armour announced a round of leadership changes it says are related to its “Protect this House 3” strategy which aims to drive U.S. sales. Chief Operating Officer Colin Browne, who served as interim CEO from June 2022 through February, is leaving the company this fall. Chief Product Officer Lisa Collier also plans to leave the company in August. Jim Dausch becomes chief consumer officer effective July 24. He will lead the company’s global brand, marketing, digital engagement and customer experience across all commerce channels. 
  • New Weight Loss Drugs Take Over For Ozempic
    Move over Ozempic, your 15 minutes of fame is fading fast, as evidenced by presentations at the American Diabetes Association meeting in San Diego.  "The drug will still be widely used, but a bewildering array of medications for obesity is advancing through development, and in the coming years, they will become a bewildering array of options for patients," per The Atlantic, including a compound called retatrutide which is perhaps the best of all, with effects approaching those of bariatric surgery.
  • Overstock.com To Become Bed Bath & Beyond
    Overstock.com will soon take on a new moniker: Bed Bath & Beyond.  "The change comes following a judge’s approval of Overstock’s purchase of the bankrupt brand’s name, domain and loyalty program assets earlier this week for more than $21 million," per CNN. "However, the acquisition doesn’t include the Bed Bath & Beyond brick-and-mortar stores, which are closing."
  • Volvo Signs Deal With Tesla To Use Charging System
    Volvo Cars is the latest automaker to announce it has signed a deal with Tesla to use its charging system.  "Under the deal, Volvo’s EVs will be equipped with Tesla-designed plugs, called the North American Charging Standard, starting in 2025," per CNBC. "Volvo’s deal with Tesla appears identical to deals struck in recent weeks by Ford Motor, General Motors and Rivian. While other rivals, including Hyundai and Chrysler parent Stellantis have said they are considering similar moves, Volvo is the first European EV maker to formally commit to the NACS charging standard for its EVs sold in North America."
  • British Boot Maker Struggles Financially
    Hunter, the maker of the popular Wellington boot, worn by the likes of Princess Diana, Kate Moss, Cara Delevingne and Alexa Chung, has filed for the British version of bankruptcy protection. "Pandemic-related supply chain problems, Brexit and inflation all played their part. However the company largely blamed the dry-up in demand to unseasonably warm weather in its largest market: the United States,"  per The New York Times. "Online, however, some customers also aired their theories on what had gone wrong. Namely, that Hunter’s offshoring of production to China had led to stumbles in quality control, resulting in split rubber and sodden toes."
  • Jack In The Box Uses AI To Analyze Customer Feedback
    Jack in the Box is the latest to jump on the artificial intelligence bandwagon. "The quick-service hamburger chain, which utilizes the AI-based location intelligence platform from SiteZeus to identify areas across the country where consumers are most likely to visit a Jack in the Box restaurant, is now deploying InMoment Spotlight AI analytics software," per Chain Store Age. The aim is to improve the clarity of customer feedback for both structured and unstructured data that includes social media, videos and audio files. 
  • Best Use Of AI In Medicine: Reducing Paperwork
    Artificial Intelligence might not save a patient's life directly, but it could free up some time for doctors, who are drowning in paperwork. "ChatGPT-style artificial intelligence is coming to health care, and the grand vision of what it could bring is inspiring. Every doctor, enthusiasts predict, will have a superintelligent sidekick, dispensing suggestions to improve care," per The New York Times. 'But first will come more mundane applications of artificial intelligence. A prime target will be to ease the crushing burden of digital paperwork that physicians must produce, typing lengthy notes into electronic medical records required for treatment, billing and …
  • Buffet Lines Are Back Post-Pandemic
    It was a no-brainer during the height of the COVID-19 pandemic that buffet lines would disappear. But even though germs are still among us, communal eating has regained its popularity. "The media called buffets zombie companies — we didn’t know we were dead,” says Lance Trenary, the chief executive of Golden Corral, whose 360 restaurants offer unlimited helpings of 150 different items for less than $20. “But we’re the comeback kids. Year to date, we’re running about 20 percent up.”
  • Weight Loss Pills Will Replace Injectables
    Move over, Ozempic and Wegovy injections, there's a replacement pill on the way. "Although still likely several years away, pills could address the second two concerns, experts say," per USA Today. "Pills, technically called oral small molecules, are far easier to manufacture, so also could address the shortages that have made it hard to access weight-loss medications for the last year or more."
« Previous Entries